| pubmed-article:19351756 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C1261473 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C0677043 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C1511572 | lld:lifeskim |
| pubmed-article:19351756 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:19351756 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:19351756 | pubmed:dateCreated | 2009-4-16 | lld:pubmed |
| pubmed-article:19351756 | pubmed:abstractText | In patients with soft-tissue sarcoma (STS), the early assessment of treatment responses is important. Using positron emission tomography/computed tomography (PET/CT) with [(18)F]fluorodeoxyglucose (FDG), we determined whether changes in tumor FDG uptake predict histopathologic treatment responses in high-grade STS after the initial cycle of neoadjuvant chemotherapy. | lld:pubmed |
| pubmed-article:19351756 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19351756 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19351756 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19351756 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19351756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19351756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19351756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19351756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19351756 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19351756 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19351756 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:19351756 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:CzerninJohann... | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:PhelpsMichael... | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:ElashoffDavid... | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:DrySarah MSM | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:WeberWolfgang... | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:EilberFritz... | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:ChowKiraK | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:EvilevitchVla... | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:Allen-Auerbac... | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:TapWilliam... | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:BenzMatthias... | lld:pubmed |
| pubmed-article:19351756 | pubmed:author | pubmed-author:EckardtJeff... | lld:pubmed |
| pubmed-article:19351756 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19351756 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:19351756 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:19351756 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19351756 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19351756 | pubmed:pagination | 2856-63 | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:meshHeading | pubmed-meshheading:19351756... | lld:pubmed |
| pubmed-article:19351756 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19351756 | pubmed:articleTitle | FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. | lld:pubmed |
| pubmed-article:19351756 | pubmed:affiliation | Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095-1782, USA. | lld:pubmed |
| pubmed-article:19351756 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19351756 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:19351756 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19351756 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19351756 | lld:pubmed |
